Business · 19/03/2012
FDA Releases Draft Guidance for Nucleic Acid-Based In Vitro Diagnostic Devices for Tuberculosis Detection
The FDA has published a draft guidance document to support the reclassification of devices for detecting tuberculosis from class III to class II, aiming to aid in the diagnosis of pulmonary tuberculosis
Original source language: Federal Register — Food and Drug AdministrationOpen original release →